Table 4:

Medication use among study participants.

Medication class	FSHD	Control
Angiotensin-converting enzyme (ACE) inhibitors	1	1
Antacids	1	0
Anticholinergics/antimuscarinics	1	0
Antifungals	1	0
Atypical antipsychotics	0	1
Calcium-channel blockers	0	1
Corticosteroids	1	0
HMG-CoA reductase inhibitors	1	1
Lincomycin antibiotics	0	1
Norepinephrine-dopamine reuptake inhibitors	1	0
NSAIDs	2	0
Proton pump inhibitors	1	1
Selective serotonin and norepinephrine reuptake inhibitors (SNRIs)	1	0
Selective serotonin receptor agonists (SSRAs)	1	0
Selective serotonin reuptake inhibitors (SSRIs)	1	1
Supplements	8	2
Tricyclic antidepressants	1	0
Vasodilators	1	0
Total medications	23	9